El Salvador vs North Macedonia: Deaths from Parkinson's disease
El Salvador
281.22 deaths
in 2021
North Macedonia
295.76 deaths
in 2021
El Salvador rank
88th
North Macedonia rank
87th
Deaths from Parkinson's disease over time
- El Salvador
- North Macedonia
How they compare
North Macedonia currently reports 295.76 deaths against 281.22 deaths in El Salvador, a difference of 14.54 deaths.
That makes North Macedonia's figure about 1.1 times El Salvador's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was El Salvador ahead.
El Salvador ranks 88th and North Macedonia ranks 87th of 194 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 191.39 deaths | 48.28 deaths | 143.11 deaths | El Salvador |
| 2010s | 266.39 deaths | 142.43 deaths | 123.96 deaths | El Salvador |
| 2020s | 293.47 deaths | 293.04 deaths | 0.425 deaths | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, El Salvador or North Macedonia?
- North Macedonia, at 295.76 deaths against 281.22 deaths in El Salvador as of 2021.
- What is the difference in deaths from parkinson's disease between El Salvador and North Macedonia?
- 14.54 deaths, with North Macedonia ahead.
- How many years of comparable data are there for El Salvador and North Macedonia?
- 22 years are reported by both, from 2000 to 2021.
- How do El Salvador and North Macedonia rank globally for deaths from parkinson's disease?
- El Salvador ranks 88th and North Macedonia ranks 87th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.